Home › Phase III data show investigational compound empagliflozin...
 

Keywords :   


Phase III data show investigational compound empagliflozin...

2013-06-22 19:08:23| Biotech - Topix.net

In the pooled analysis, presented at the American Diabetes Association 73rd Scientific SessionsA , people with T2D treated with empagliflozin versus placebo achieved significant reductions in HbA1c, fasting plasma glucose , weight and blood pressure after 24 weeks.1 In the same analysis, people treated with empagliflozin vs. placebo experienced an ... (more)

Tags: show data iii phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
11.10Tropical Storm Leslie Graphics
11.10Tropical Storm Leslie Forecast Discussion Number 36
11.10Tropical Storm Leslie Wind Speed Probabilities Number 36
11.10Tropical Storm Leslie Public Advisory Number 36
11.10Summary for Tropical Storm Leslie (AT3/AL132024)
11.10Tropical Storm Leslie Forecast Advisory Number 36
11.10China detains iPhone maker workers in 'strange' case
11.10UK economy returned to growth in August
More »